3d
Hosted on MSNHims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugsThe telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...
As the Philadelphia Eagles romped to victory against the Kansas City Chiefs in the Super Bowl LIX, the eyes of the pharmaceutical industry were on an advert aired by telehealth company Him & Hers ...
4don MSNOpinion
The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...
4d
GlobalData on MSNSuper Bowl ad for copycat weight loss drugs stokes pharma power debateControversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting event.
The ad promotes affordable alternatives to expensive weight loss drugs, claiming the system prioritizes profits over patient health. Concerns have been raised by the Partnership for Safe Medicines ...
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
Experts, advocates and politicians are saying that the 60-second spot — which deems obesity “America’s deadliest epidemic,” criticizes the $160 billion weight loss industry and calls ... is trying to ...
Drug industry allies are calling out a Super Bowl ad touting its weight loss medications from telehealth company Hims & Hers, claiming the spot doesn't adequately disclose safety risks of these drugs.
Hims & Hers makes its Super Bowl commercial debut in 2025 with a spot for the telehealth company's weight ... loss industry that "feeds on our failure." Drug industry groups took issue with the ad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results